Latest Nucleosides Stories

2008-08-22 06:00:10

Celgene has announced that Vidaza has received expanded FDA approval to reflect new overall survival achieved in the AZA-001 survival study of patients with higher-risk myelodysplastic syndromes.

2008-08-21 12:01:28

The Aplastic Anemia & MDS International Foundation (AA&MDSIF) is pleased to inform patients that the U.S.

2008-08-05 06:00:46

Clinical Data, Inc. (NASDAQ:CLDA) today announced the acquisition of Adenosine Therapeutics, L.L.C., a developer of drug products based on its extensive portfolio of composition of matter and method of use patents relating to selective adenosine receptor modulators.

2008-07-28 09:01:47

NEW YORK, July 28 /PRNewswire/ -- AIM Pharmakon, Inc. (API), a New York-based company, announced today the introduction of the next generation of high-level cardiovascular health and longevity products starting with Aim Endurance(TM), a new premium quality liquid concentrate.

2006-11-21 03:00:23

BOULDER, Colo., and KYOTO, Japan, Nov. 21 /PRNewswire-FirstCall/ -- Pharmion Corporation and Nippon Shinyaku Co., Ltd today announced the completion of an exclusive license agreement for development and commercialization rights to Vidaza (azacitidine for injectable suspension) in Japan.

Word of the Day
  • A coin originally worth six pennies Scots, and later three; held equivalent to an English halfpenny.
  • (in plural) Money; cash.